120 related articles for article (PubMed ID: 26766917)
21. Featured article: autophagic activation with nimotuzumab enhanced chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma.
Song H; Pan B; Yi J; Chen L
Exp Biol Med (Maywood); 2014 May; 239(5):529-41. PubMed ID: 24625442
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysis.
Li J; Gong Y; Diao P; Huang Q; Wen Y; Lin B; Cai H; Tian H; He B; Ji L; Guo P; Miao J; Du X
Radiat Oncol; 2018 Jan; 13(1):12. PubMed ID: 29357883
[TBL] [Abstract][Full Text] [Related]
23. Nimotuzumab with cisplatin or fluorouracil on human esophageal squamous cell carcinoma EC1 cells.
Ji YH; Yang XY; Wu JQ; Huo XQ; Li WW; Li GJ; Mu YL; Lu P
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):586-91. PubMed ID: 25753875
[TBL] [Abstract][Full Text] [Related]
24. Study on chemotherapeutic sensitizing effect of nimotuzumab on different human esophageal squamous carcinoma cells.
Yang X; Ji Y; Kang X; Chen M; Kou W; Jin C; Lu P
Oncol Lett; 2016 Feb; 11(2):973-978. PubMed ID: 26893678
[TBL] [Abstract][Full Text] [Related]
25. Salvage lymphadenectomy versus salvage radiotherapy/chemoradiotherapy for recurrence in cervical lymph node after curative resection of esophageal squamous cell carcinoma.
Ma X; Zhao K; Guo W; Yang S; Zhu X; Xiang J; Zhang Y; Li H
Ann Surg Oncol; 2015 Feb; 22(2):624-9. PubMed ID: 25155397
[TBL] [Abstract][Full Text] [Related]
26. Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer.
Takeda M; Okamoto I; Nishimura Y; Nakagawa K
Lung Cancer (Auckl); 2011; 2():59-67. PubMed ID: 28210119
[TBL] [Abstract][Full Text] [Related]
27. Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.
Hu G; Wang Z; Wang Y; Zhang Q; Tang N; Guo J; Liu L; Han X
Drug Des Devel Ther; 2016; 10():2129-36. PubMed ID: 27445460
[TBL] [Abstract][Full Text] [Related]
28. [The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma].
Ni WJ; Deng W; Xiao ZF; Zhou ZM; Wang X; Chen DF; Feng QF; Liang J; Lyu JM; Bi N; Deng L; Zhang T; Wang WQ; Xue Q; Gao SG; Mu JW; Mao YS; Wang DL; Zhao J; Gao YS; Huang JF; Tan FW; Zhao L; Lyu F; Zhang GC
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):295-302. PubMed ID: 31014056
[No Abstract] [Full Text] [Related]
29. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
Xu X; Wang Z; Jiang S; Shang Y; Wu Y
Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and toxicity of nimotuzumab combined with radiotherapy in elderly patients with esophageal squamous cell carcinoma.
Guo JH; Chen MQ; Chen C; Lu HJ; Xu BH
Mol Clin Oncol; 2015 Sep; 3(5):1135-1138. PubMed ID: 26623065
[TBL] [Abstract][Full Text] [Related]
31. Primary mucoepidermoid carcinoma of the esophagus.
Chen S; Chen Y; Yang J; Yang W; Weng H; Li H; Liu D
J Thorac Oncol; 2011 Aug; 6(8):1426-31. PubMed ID: 21587086
[TBL] [Abstract][Full Text] [Related]
32. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
[TBL] [Abstract][Full Text] [Related]
33. A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01).
Kim HR; Jang JS; Sun JM; Ahn MJ; Kim DW; Jung I; Lee KH; Kim JH; Lee DH; Kim SW; Cho BC
Oncotarget; 2017 Feb; 8(9):15943-15951. PubMed ID: 27823977
[TBL] [Abstract][Full Text] [Related]
34. [IMRT-based preoperative neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma (ESCC): an analysis of outcome and prognosis].
Men Y; Hui ZG; Liang J; Feng QF; Chen DF; Zhang HX; Xiao ZF; Zhou ZM; Wang LH
Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):682-6. PubMed ID: 27647401
[TBL] [Abstract][Full Text] [Related]
35. A phase I study evaluating combined nimotuzumab and neoadjuvant chemoradiotherapy followed by surgery in locally advanced esophageal cancer.
Qi S; Mao Y; Jiang M
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1115-1123. PubMed ID: 31502113
[TBL] [Abstract][Full Text] [Related]
36. Case Report: Primary and Acquired Resistance Mechanisms of Nimotuzumab in Advanced Esophageal Squamous Cell Carcinoma Revealed by Targeted Sequencing.
Sun D; Yan W; Zhu H; Liu Q; Hou H
Front Oncol; 2020; 10():574523. PubMed ID: 33194681
[TBL] [Abstract][Full Text] [Related]
37. [Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma].
Huang XD; Yi JL; Gao L; Xu GZ; Jin J; Yang WZ; Lu TX; Wu SX; Wu RR; Hu WH; Xie WC; Han F; Gao YH; Gao JM; Pan JJ; Chen CB; Lang JY; Li T; Dong Y; Fu YB; Fan L; Li BS; Li J; Wang XH; Chen BX; Gao XS; Zhang P; Wu XW; Hu BQ
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):197-201. PubMed ID: 17649636
[TBL] [Abstract][Full Text] [Related]
38. EGFR Expression in Patients with Esophageal Squamous Cell Carcinoma and its Association with Pathologic Response to Preoperative Chemoradiotherapy: A Study in Northeastern Iran.
Anvari K; Sima HR; Seilanian Toussi M; Anvari A; Shahidsales S; Memar B; Aledavoud SA; Forghani MN; Abdollahi A; Ghaffarzadegan K
Arch Iran Med; 2017 Apr; 20(4):240-245. PubMed ID: 28412829
[TBL] [Abstract][Full Text] [Related]
39. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
Chen J; Yin W; Yao H; Gu W
Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
[TBL] [Abstract][Full Text] [Related]
40. [Clinical value of barium swallow in observing esophageal tumor regression during radiotherapy].
Li QQ; Liu MZ; Hu YH; Liu H; Huang Y; Cui NJ
Ai Zheng; 2006 Jun; 25(6):723-7. PubMed ID: 16764768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
